dc.contributor.author |
Huaquiá-Diáz, A.M. |
|
dc.contributor.author |
Chalán-Dávila, T.S. |
|
dc.contributor.author |
Carrillo Larco, Rodrigo Martín |
|
dc.contributor.author |
Bernabé Ortiz, Antonio |
|
dc.date.accessioned |
2021-10-04T23:00:59Z |
|
dc.date.available |
2021-10-04T23:00:59Z |
|
dc.date.issued |
2021 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/9857 |
|
dc.description.abstract |
Objective To estimate the pooled prevalence of multimorbidity (≥2 non-communicable diseases in the same individual) among adults of the general population of Latin American and the Caribbean (LAC). Design Systematic review and meta-analysis. Data sources MEDLINE, Embase, Global Health, Scopus and LILACS up to 1 July 2020. Eligibility criteria for selecting studies The outcome was the prevalence of multimorbidity. Reports were selected whether they enrolled adult individuals (age ≥18 years) from the general population. Data extraction and synthesis Reviewers extracted relevant data and assessed risk of bias independently. A random-effects meta-analysis was conducted to report pooled prevalence estimates of multimorbidity; pooled estimates by pre-specified subgroups (eg, national studies) were also pursued. Results From 5830 results, we selected 28 reports, mostly from Brazil and 16 were based on a nationally representative sample. From the 28 selected reports, 26 were further included in the meta-analysis revealing a pooled multimorbidity prevalence of 43% (95% CI: 35% to 51%; I 2: 99.9%). When only reports with a nationally representative sample were combined, the pooled prevalence was 37% (95% CI: 27% to 47%; I 2: 99.9%). When the ascertainment of multimorbidity was based on self-reports alone, the pooled prevalence was 40% (95% CI: 31% to 48%; I 2: 99.9%); this raised to 52% (95% CI: 33% to 70%; I 2: 99.9%) for reports including self-reported and objective diagnosis. Conclusions Our results complement and advance those from global efforts by incorporating much more reports from LAC. We revealed a larger presence of multimorbidity in LAC than previously reported |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
BMJ Publishing Group |
|
dc.relation.ispartofseries |
BMJ Open |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
adolescent |
en_US |
dc.subject |
Adolescent |
en_US |
dc.subject |
Brazil |
en_US |
dc.subject |
Caribbean |
en_US |
dc.subject |
Caribbean Region |
en_US |
dc.subject |
diabetes & endocrinology |
en_US |
dc.subject |
epidemiology |
en_US |
dc.subject |
human |
en_US |
dc.subject |
Humans |
en_US |
dc.subject |
hypertension |
en_US |
dc.subject |
Latin America |
en_US |
dc.subject |
meta analysis |
en_US |
dc.subject |
Multimorbidity |
en_US |
dc.subject |
multiple chronic conditions |
en_US |
dc.subject |
prevalence |
en_US |
dc.subject |
Prevalence |
en_US |
dc.subject |
public health |
en_US |
dc.subject |
South and Central America |
en_US |
dc.title |
Multimorbidity in Latin America and the Caribbean: A systematic review and meta-analysis |
en_US |
dc.type |
info:eu-repo/semantics/review |
|
dc.identifier.doi |
https://doi.org/10.1136/bmjopen-2021-050409 |
|
dc.relation.issn |
2044-6055 |
|